Literature DB >> 9665417

Cardiac troponin T in hemodialyzed patients.

D S Ooi1, A A House.   

Abstract

We studied the extent and pattern of increased cardiac troponin T (cTnT) concentrations in 174 hemodialyzed patients. cTnT concentrations were above 0.10 and 0.20 microg/L in 29% and 10% of patients, respectively. In patients without acute coronary disease, the highest value observed was 3.2 microg/L. cTnT increased after dialysis in 10 of 12 patients, with a mean increase of 0.14 microg/L. In 125 patients with samples taken at 1-month intervals, 34% of patients showed differences <20%, but 16% of patients had differences greater than twofold. Serum creatinine and urea, adequacy of dialysis, and duration on dialysis did not explain increased concentrations. Sixty percent of 57 diabetic patients had increased concentrations; the patients with multiple diabetic complications had the highest positivity. cTnT was increased in all eight patients with complications of neuropathy, retinopathy, coronary, and peripheral vascular disease; in 80% of patients with neuropathy; in 77% with peripheral vascular disease; in 73% with retinopathy; and in 70% with coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9665417

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  15 in total

1.  Decoding Acute Myocardial Infarction among Patients on Dialysis.

Authors:  Charles E Howard; Peter A McCullough
Journal:  J Am Soc Nephrol       Date:  2017-04-12       Impact factor: 10.121

Review 2.  Troponin: the biomarker of choice for the detection of cardiac injury.

Authors:  Luciano Babuin; Allan S Jaffe
Journal:  CMAJ       Date:  2005-11-08       Impact factor: 8.262

3.  Troponin T for the detection of dialysis-induced myocardial stunning in hemodialysis patients.

Authors:  Tobias Breidthardt; James O Burton; Aghogho Odudu; Mohamed Tarek Eldehni; Helen J Jefferies; Christopher W McIntyre
Journal:  Clin J Am Soc Nephrol       Date:  2012-07-19       Impact factor: 8.237

4.  Cardiac troponins T and I in patients with end-stage renal disease: the relation with left ventricular mass and their prognostic value.

Authors:  Adnan Abaci; Eyup Ekici; Abdurrahman Oguzhan; Bulent Tokgoz; Cengiz Utas
Journal:  Clin Cardiol       Date:  2004-12       Impact factor: 2.882

5.  Effect of hemodialysis, coronary artery disease and diabetes on cardiac troponin T: a prospective survey over one year.

Authors:  François-Pierre Mongeon; Marc Dorais; Jacques Le Lorier; Daniel Froment; Elaine Letendre; Stéphane Rinfret
Journal:  Open Cardiovasc Med J       Date:  2009-06-24

6.  Biomarkers in predicting mortality and treatment in hemodialysis patients.

Authors:  Angela Yee-Moon Wang
Journal:  F1000 Med Rep       Date:  2009-03-17

7.  Plasma levels of brain natriuretic peptides and cardiac troponin in hemodialysis patients.

Authors:  Halima Resić; Selma Ajanović; Nihad Kukavica; Fahrudin Masnić; Aida Corić
Journal:  Bosn J Basic Med Sci       Date:  2009-05       Impact factor: 3.363

8.  Improving prognosis estimation in patients with heart failure and the cardiorenal syndrome.

Authors:  Husam M Abdel-Qadir; Shaan Chugh; Douglas S Lee
Journal:  Int J Nephrol       Date:  2011-05-18

9.  Chapter 4: Other complications of CKD: CVD, medication dosage, patient safety, infections, hospitalizations, and caveats for investigating complications of CKD.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2013-01

10.  Independent value of cardiac troponin T and left ventricular global longitudinal strain in predicting all-cause mortality among stable hemodialysis patients with preserved left ventricular ejection fraction.

Authors:  Junne-Ming Sung; Chi-Ting Su; Yu-Tzu Chang; Yu-Ru Su; Wei-Chuan Tsai; Saprina P H Wang; Chun-Shin Yang; Liang-Miin Tsai; Jyh-Hong Chen; Yen-Wen Liu
Journal:  Biomed Res Int       Date:  2014-05-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.